<SEC-DOCUMENT>0001641172-25-014002-index.html : 20250606
<SEC-HEADER>0001641172-25-014002.hdr.sgml : 20250606
<ACCEPTANCE-DATETIME>20250606151325
ACCESSION NUMBER:		0001641172-25-014002
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250606
DATE AS OF CHANGE:		20250606

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FibroBiologics, Inc.
		CENTRAL INDEX KEY:			0001958777
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				863329066
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94820
		FILM NUMBER:		251030220

	BUSINESS ADDRESS:	
		STREET 1:		455 E. MEDICAL CENTER BLVD
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77598
		BUSINESS PHONE:		281-671-5150

	MAIL ADDRESS:	
		STREET 1:		455 E. MEDICAL CENTER BLVD SUITE 300
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77598

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FibroBiologics Inc.
		DATE OF NAME CHANGE:	20221216

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Newlin Michael F.
		CENTRAL INDEX KEY:			0002067695
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	MAIL ADDRESS:	
		STREET 1:		1414 HORSESHOE DR.
		CITY:			SUGAR LAND
		STATE:			TX
		ZIP:			77478
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>